Fig. 6 | Scientific Reports

Fig. 6

From: Outcome prediction model for patients with unresectable hepatocellular carcinoma treated with targeted therapy

Fig. 6

Predictions of the TUHP OS and PFS models. Comparisons of the A AUCs and B C-indices of the different risk stratification models for OS in internal the validation cohort, as well as comparisons of the C AUCs and D C-indices of the different risk stratification models for PFS in the internal validation cohort. In all figures, the AUC and C-index values of the TUHP models are the highest. ROC receiver operating characteristic, AUC area under the curve, CI confidence interval, TUHP targeted therapy for unresectable hepatocellular prognosis, BCLC Barcelona Clinic Liver Cancer, CNLC Chinese Liver Cancer, HAP Hepatoma Arterial Embolization Prognostic system, PROSASH-II Prediction of Survival in Advanced Sorafenib-Treated Hepatocellular Carcinoma-II, C-index concordance index, OS overall survival, PFS progression-free survival.

Back to article page